Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Java Original Coffee Company to Support The Onco'Zine Brief Radio Broadcast and Podcast


News provided by

Java Origina Coffee Company, LLC

Jan 25, 2023, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Youtube
Youtube

The Java Original Coffee Company, the home of incredible artisan roasted gourmet coffee, is committed to support the cancer research community as well as select individuals and organizations involved in the treatment of (pediatric) cancer patients. Java Original Coffee also supports select organizations developing continued education programs for physicians and ongoing healthcare information programs for (cancer) patient and their family & friends. The Onco'Zine Brief, a radio show and podcast about (new) research findings in cancer, cancer prevention, - diagnoses, - treatment, is one of the 13 recipients chosen by the Java Original Coffee Company to benefit from the company's 'Shop-for-a-Cause/Make a Difference' campaign.

CHANDLER, Ariz. and NEW YORK, Jan. 25, 2023 /PRNewswire-PRWeb/ -- Today, the Java Original Coffee Company announced that it is partnering with The Onco'Zine Brief, a radio broadcast and podcast about research findings in cancer, as well as cancer prevention, - diagnoses, and - treatment, for an ongoing two-year sponsorship. As part of the agreement, a percentage of earnings from online premium coffee purchases will be set aside to support the production of new episodes of The Onco'Zine Brief, and expand the broadcast's syndication.

The sponsorship is part of the Java Original Coffee Company's commitment to support the cancer (research) community and help physicians, including oncologists and hematologists (and other healthcare professionals) empower people, (cancer) patients and their family and friends with accurate information about cancer prevention, -diagnoses, -treatment.

The support from the Java Original Coffee Company helps us produce The Onco'Zine Brief and create awareness for difficult to treat cancers and topics including disparities in healthcare and access to cancer care as well as cancer prevention, -treatment and -diagnosis.

Post this

Why cancer?
According to the American Cancer Society, overall cancer mortality has dropped 33% since 1991, averting an estimated 3.8 million cancer deaths. In a recent publication, the American Cancer Society, also said that in 2023 there are projected to be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States. [1] Some of these cancers may be prevented by specific prevention strategies and early diagnosis. However, cancer prevention requires that people have the right information and access to healthcare. In creating the 'Shop-for-a-Cause/Make a Difference,' campaign, Java Original Coffee Company is committed to support 13 organizations involved in (cancer) research and treatment and in the development of continued education programs for physicians and ongoing healthcare information programs for (cancer) patient and their family & friends. As part of this commitment, Java Original Coffee Company donates 3.25% of earnings of all online purchases of premium roasted artisan coffees.

"We are really grateful to be chosen by the Java Original Coffee Company," said Peter Hofland, Ph.D., executive editor and co-publisher of Onco'Zine and ADC Review | Journal of Antibody-drug Conjugates and host of The Onco'Zine Brief.

"The focused commitment to support the development of continued education programs for physicians and information programs for (cancer) patient and their family & friends, makes the Java Original Coffee Company the perfect partner in helping us to create awareness for difficult to treat cancers, as well as discuss novel drug development, new and advanced cancer treatment modalities, prevention and (early) diagnosis, but also topics such as disparities in health and access to (cancer) care," he noted.

"Our plans for 2023 and 2024 includes increasing the number of programs and expand the syndication of The Onco'Zine Brief. The support we receive from the Java Original Coffee Company allows us to expand our reach so that The Onco'Zine Brief can be heard on-air in more cities in the United States. This support also helps us to expand our editorial and production team and, in collaboration with Onco'Zine and ADC Review | Journal of Antibody-drug Conjugates, offer additional programming during important medical society meetings in the United States, Europe and Asia," Hofland concluded.

About The Onco'Zine Brief
The Onco'Zine Brief is an interview and discussion program covering a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The program is a sponsor-supported broadcast and podcast for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends.

The Onco'Zine Brief is distributed in the United States via PRX (Public Radio Exchange). In the United Kingdom and Europe, the program is distributed via UK Health Radio (UKHR). The program can also be downloaded via most podcasts and streaming media services, including Audible, Spotify, Goodpods, Apple Podcast/iTunes, YouTube, SoundCloud, TuneIn, Google Podcasts, iHeart Radio and others.

For more information about how to sponsor or support The Onco'Zine Brief radio broadcast and podcast, schedule coverage of of conferences and/or medical society meetings (in association with Onco'Zine and ADC Review | Journal of Antibody-drug Conjugates), download our Media Kit or visit our Patreon page.

For more information about cancer and cancer treatments visit Onco'Zine. To sign up for The Onco'Zine Newsletter (open for residents of the United States only), text the word CANCER to 66866.

About Java Original Coffee Company
With a history dating back to 1842, the Java Original Coffee Company is the home of incredible artisan roasted gourmet coffee. Our mission is to offer the best artisan roasted coffee to our customers and create the best work environment, training, and support for our staff. We source our coffees from all over the world, and our seasonal whole bean coffee menu is curated to offer something special for everyone.

With our 'Shop-for-a-Cause/Make a Difference' campaign we donate a percentage of our earnings to support the cancer research community, individuals and organizations involved in the treatment of (pediatric) cancer patients, and organizations developing continued education programs for physicians and ongoing healthcare information programs for (cancer) patient and their family & friends.

In addition to sponsoring The Onco'Zine Brief, Java Original Coffee also donates a percentage of earnings from online premium coffee purchases to organizations including: St. Jude Children's Research Hospital; American Cancer Society; Breast Cancer Research Foundation; Phoenix Children's Hospital Foundation; Bear Necessities Pediatric Cancer Foundation; Ovarian Cancer Connection; GO2 Foundation for Lung Cancer; American Association For Cancer Research; Conquer Cancer Foundation; The Sarcoma Foundation of America; Lymphoma Research Foundation, and the Ben and Catherine Ivy Foundation.

Reference
Cancer Facts & Figures 2023, American Cancer Society. Online. Last accessed on January 17, 2023.

Media Contact

Kindra Deneau (CONSULTANT), Java Origina Coffee Company, LLC, (480) 626 7218, [email protected]

SOURCE Java Origina Coffee Company, LLC

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.